Physician profile
Brian Christopher Reuben
NPI 1447457221
$6,161.56
in general payments reported to CMS, 2019-2025
8 companies · $585 in 2025
The $585 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,329 · 2020: $953 · 2021: $554 · 2022: $279 · 2023: $231 · 2024: $231 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.44 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,515.07 | 2019-2022 | |
| Baxter Healthcare | $848.53 | 2019-2021 | |
| Sientra, INC. | $702.72 | 2019-2022 | |
| Abbvie INC. | $514.74 | 2023-2025 | |
| Integra Lifesciences Corporation | $500.28 | 2023-2025 | Durasorb Monofilament Mesh |
| Axogen | $48.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.06 | 2025 | |
| Mentor Worldwide LLC | $14.16 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Reuben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.